Skip to search formSkip to main contentSkip to account menu

Vincamine

Known as: Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16alpha)-, Vincamine [Chemical/Ingredient] 
A major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in… 
National Institutes of Health

Related topics

Related topics

23 relations

Narrower (13)

11-bromovincamineCerebroxineDevincanPervincamine

Broader (3)

Antihypertensive AgentsVasodilator AgentsVinca Alkaloids
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Separation of vinca alkaloid enantiomers by capillary electrophoresis applying cyclodextrin derivatives and characterization of cyclodextrin complexes by nuclear magnetic resonance spectroscopy.
1996
1996
Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors.
Review
1995
Review
1995
Therapeutic approaches for memory impairments
1991
1991
Effects of several cerebroprotective drugs on NMDA channel function: evaluation using Xenopus oocytes and [3H]MK-801 binding.
Review
1989
Review
1989
The Families of Cognition Enhancers
An attempt has been made to classify the numerous drugs used to treat cognition deficits according to their chemical structures… 
1988
1988
Comparison of the effects of vinpocetine, vincamine, and nicergoline on the normal and hypoxia‐damaged learning process in spontaneously hypertensive rats
Vinpocetine (Cavinton®), vincamine, and nicergoline (Sermion®) were evaluated for the ability to protect cognitive function of… 
Highly Cited
1987
Highly Cited
1987
Buflomedil
SummarySynopsisBuflomedil hydrochloride1is a vasoactive drug with a variety of pharmacodynamic properties. Importantly, it seems… 
Highly Cited
1986
Highly Cited
1986
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
Hexyl cyanoacrylate nanoparticles loaded with vincamine as a drug model were prepared. Disposition kinetics and oral… 
1985
1985
Alteration of enzymes in ageing human fibroblasts in culture. III. Modification of superoxide dismutase as an environmental and reversible process
1984
1984
Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)